Lungnakrabbamein - Yfirlitsgrein

Translated title of the contribution: Lung cancer - Review

Tómas Guǒbjartsson*, Agnes Smáradóttir, Halla Skúladóttir, Hlynur N. Grímsson, Hrönn Harðardóttir, Jóhannes Björnsson, P. Pétur Hannesson, Sigríður Ólína Haraldsdóttir, Steinn Jónsson

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

5 Citations (Scopus)


Lung cancer is the second most common cancer in Iceland and the most frequent cause of cancer related deaths. Smoking is by far the most important cause but familial factors also contribute. The symptoms of lung cancer are often subtle and the diagnosis, in about 70% of cases, is made when metastases have occurred. Curative surgical treatment is therefore only possible in about a third of the cases whereas other patients receive chemotherapy and/or radiation therapy. In recent years some important advances have been made in the diagnostic and therapeutic approaches to lung cancer. New imaging techniques have improved diagnosis and staging practices and consequently also treatment. Recent evidence suggests that screening with low dose CT may improve survival. New approaches to chemotherapy have been shown to improve survival and well being of patients with advanced disease. Chemotherapeutic agents are now being used in conjunction with surgery to reduce the risk of tumour spread. Furthermore, advances in surgical techniques have made resections possible in cases deemed inoperable in the past. In this review we present important advances in the diagnosis and treatment of lung cancer as reflected by recent literature that should be of interest to a wide variety of specialists.

Translated title of the contributionLung cancer - Review
Original languageIcelandic
Pages (from-to)297-311
Number of pages15
Issue number4
Publication statusPublished - 2008


Dive into the research topics of 'Lung cancer - Review'. Together they form a unique fingerprint.

Cite this